Literature DB >> 10906330

Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library.

S J Deng1, D M Bickett, J L Mitchell, M H Lambert, R K Blackburn, H L Carter, J Neugebauer, G Pahel, M P Weiner, M L Moss.   

Abstract

The substrate specificity of human collagenase 3 (MMP-13), a member of the matrix metalloproteinase family, is investigated using a phage-displayed random hexapeptide library containing 2 x 10(8) independent recombinants. A total of 35 phage clones that express a peptide sequence that can be hydrolyzed by the recombinant catalytic domain of human collagenase 3 are identified. The translated DNA sequence of these clones reveals highly conserved putative P1, P2, P3 and P1', P2', and P3' subsites of the peptide substrates. Kinetic analysis of synthetic peptide substrates made from human collagenase 3 selected phage clones reveals that some of the substrates are highly active and selective. The most active substrate, 2, 4-dinitrophenyl-GPLGMRGL-NH(2) (CP), has a k(cat)/K(m) value of 4.22 x 10(6) m(-)(1) s(-)(1) for hydrolysis by collagenase 3. CP was synthesized as a consensus sequence deduced from the preferred subsites of the aligned 35 phage clones. Peptide substrate CP is 1300-, 11-, and 820-fold selective for human collagenase 3 over the MMPs stromelysin-1, gelatinase B, and collagenase 1, respectively. In addition, cleavage of CP is 37-fold faster than peptide NF derived from the major MMP-processing site in aggrecan. Phage display screening also selected five substrate sequences that share sequence homology with a major MMP cleavage sequence in aggrecan and seven substrate sequences that share sequence homology with the primary collagenase cleavage site of human type II collagen. In addition, putative cleavage sites similar to the consensus sequence are found in human type IV collagen. These findings support previous observations that human collagenase 3 can degrade aggrecan, type II and type IV collagens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906330     DOI: 10.1074/jbc.M004538200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Using fluorogenic peptide substrates to assay matrix metalloproteinases.

Authors:  G B Fields
Journal:  Methods Mol Biol       Date:  2001

Review 2.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

3.  IDG-SW3 Osteocyte Differentiation and Bone Extracellular Matrix Deposition Are Enhanced in a 3D Matrix Metalloproteinase-Sensitive Hydrogel.

Authors:  Aaron H Aziz; Rachel L Wilmoth; Virginia L Ferguson; Stephanie J Bryant
Journal:  ACS Appl Bio Mater       Date:  2020-02-19

Review 4.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

5.  Biomimetic matrices for myocardial stabilization and stem cell transplantation.

Authors:  Samuel T Wall; Che-Chung Yeh; Richard Y K Tu; Michael J Mann; Kevin E Healy
Journal:  J Biomed Mater Res A       Date:  2010-09-28       Impact factor: 4.396

Review 6.  Matrix metalloproteases: underutilized targets for drug delivery.

Authors:  Deepali G Vartak; Richard A Gemeinhart
Journal:  J Drug Target       Date:  2007-01       Impact factor: 5.121

7.  Inhibition of matrix metalloproteinases enhances in vitro repair of the meniscus.

Authors:  Amy L McNulty; J Brice Weinberg; Farshid Guilak
Journal:  Clin Orthop Relat Res       Date:  2008-10-31       Impact factor: 4.176

8.  Involvement of angiopoietin-like 4 in matrix remodeling during chondrogenic differentiation of mesenchymal stem cells.

Authors:  Marc Mathieu; Mathieu Iampietro; Paul Chuchana; David Guérit; Farida Djouad; Danièle Noël; Christian Jorgensen
Journal:  J Biol Chem       Date:  2014-02-06       Impact factor: 5.157

9.  Synovial fluid concentrations and relative potency of interleukin-1 alpha and beta in cartilage and meniscus degradation.

Authors:  Amy L McNulty; Nicole E Rothfusz; Holly A Leddy; Farshid Guilak
Journal:  J Orthop Res       Date:  2013-03-11       Impact factor: 3.494

10.  Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates.

Authors:  Eric M Tam; Charlotte J Morrison; Yi I Wu; M Sharon Stack; Christopher M Overall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.